share_log

亞盛醫藥-B:(I)內幕消息 — 訂立HQP1351合作及授權協議 以及APG-2575聯合治療戰略合作及臨床試驗協議; (II)根據一般授權發行新股份;及 (III)建議根據特別授權發行非上市認股權證

ASCENTAGE-B: (I) INSIDE INFORMATION - ENTRY INTO OF THE HQP1351 COLLABORATION AND LICENSE AGREEMENT AND THE APG- 2575 COMBINATION THERAPY STRATEGIC COLLABORATION AND CLINICAL TRIAL AGREEMENT; (II) ISSUANCE OF NEW SHARES UNDER GENERAL MANDATE; AND (III) PR

Jul 14, 2021 10:45
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more